Viscoelastic hemostatic assay (VHAs) are whole blood point-of-care tests that have become
an essential method for assaying hemostatic competence in liver transplantation, cardiac …

Background Severe trauma represents a major global public health burden and the
management of post-traumatic bleeding continues to challenge healthcare systems around …

Background Viscoelastic testing is a method of hemostatic analysis that provides a real‐
time, holistic view of ex vivo clotting. It allows for examination of both cellular and plasma …

Viscoelastic testing (VET), including thromboelastography and thromboelastometry,
provides a rapid and comprehensive picture of whole blood coagulation dynamics and …

Coronavirus disease 2019 (COVID-19)-associated coagulopathy (CAC), characterized by
hypercoagulability and an increased risk of thrombotic complications, is an important …

Viscoelastic-based techniques to evaluate whole blood hemostasis have advanced
substantially since they were first developed over 70 years ago but are still based upon the …

POC SCTs are not able to characterise the complexity of trauma-associated coagulopathy.
VETs provide a rapid estimation of underlying haemostatic disorders, thereby providing …

Coagulopathy induced by major trauma is common, affecting approximately one-third of
patients after trauma. It develops independently of iatrogenic, hypothermic, and dilutive …

Viscoelastic hemostatic assays (VHA) are point of care tests that allow for a global
assessment of coagulation using whole blood. The technology to allow this assessment has …

OBJECTIVES: Traumatic brain injury is associated with coagulopathy that increases
mortality risk. Viscoelastic hemostatic assays such as thromboelastography (Haemonetics …